Invenomic Capital Boosts Stake in Helen of Troy

Investment firm increases holdings in consumer products company by 68.8% in Q3

Mar. 16, 2026 at 12:20pm

Got story updates? Submit your updates here. ›

Invenomic Capital Management LP raised its stake in Helen of Troy Limited (NASDAQ:HELE) by 68.8% during the third quarter, according to a recent 13F filing. The investment firm now owns 554,985 shares of the consumer products company, worth approximately $13.99 million and representing 2.41% of Helen of Troy's outstanding stock.

Why it matters

This increase in Invenomic's position suggests the investment firm sees growth potential in Helen of Troy, a diversified consumer goods company known for brands like OXO, Vicks, and Braun. The filing provides insight into the investment strategies of Invenomic, which manages over $1 billion in assets.

The details

According to the 13F filing, Invenomic Capital Management purchased an additional 226,263 shares of Helen of Troy during the third quarter, bringing its total position to 554,985 shares. This represents a 68.8% increase from the previous quarter. Helen of Troy is a global consumer products company that designs, sources, and markets a portfolio of household, health, and beauty brands.

  • Invenomic Capital Management filed the 13F report for the third quarter of 2026.

The players

Invenomic Capital Management LP

An investment management firm that oversees over $1 billion in assets.

Helen of Troy Limited

A global consumer products company that owns brands such as OXO, Vicks, and Braun.

Got photos? Submit your photos here. ›

The takeaway

Invenomic's increased stake in Helen of Troy suggests the investment firm sees potential in the consumer products company's portfolio of well-known brands. This filing provides insight into Invenomic's investment strategy and its views on the consumer goods industry.